New triple diabetes pill tested in healthy adults – no cure, just comparison
NCT ID NCT07399470
First seen Feb 11, 2026 · Last updated May 08, 2026 · Updated 14 times
Summary
This study checks if a new single pill containing three diabetes drugs (gemigliptin, dapagliflozin, metformin) works the same as taking two separate pills. It involves 58 healthy adults aged 19-50 who receive one dose of each treatment under fasting conditions. The goal is to compare how the drugs are absorbed and tolerated, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, 54907, South Korea
Conditions
Explore the condition pages connected to this study.